Covered recipient · General Payments record
PETER J REILLY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,979.74
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $555.81 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $176.08 | 3 |
| PFIZER INC. | $132.93 | 4 |
| E.R. Squibb & Sons, L.L.C. | $110.75 | 2 |
| LEO Pharma Inc. | $78.57 | 4 |
| Arcutis Biotherapeutics, Inc. | $15.19 | 1 |
| Dermavant Sciences, Inc. | $15.08 | 1 |
| Lilly USA, LLC | $13.61 | 1 |
| STRATA Skin Sciences, Inc. | $13.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $121.35 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108073169 | CMS |
| ABBVIE INC. | $29.70 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108073171 | CMS |
| ABBVIE INC. | $25.03 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108073173 | CMS |
| Arcutis Biotherapeutics, Inc. | $15.19 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121117431 | CMS |
| Dermavant Sciences, Inc. | $15.08 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128007337 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.20 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101639892 | CMS |
| E.R. Squibb & Sons, L.L.C. | $85.55 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101639946 | CMS |
| LEO Pharma Inc. | $16.25 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152685035 | CMS |
| LEO Pharma Inc. | $15.34 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152685037 | CMS |
| LEO Pharma Inc. | $20.41 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152685039 | CMS |
| LEO Pharma Inc. | $26.57 | 11/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152685041 | CMS |
| Lilly USA, LLC | $13.61 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920814 | CMS |
| PFIZER INC. | $21.27 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131674683 | CMS |
| PFIZER INC. | $12.26 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131924186 | CMS |
| PFIZER INC. | $84.18 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131815836 | CMS |
| PFIZER INC. | $15.22 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131964599 | CMS |
| STRATA Skin Sciences, Inc. | $13.60 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146582853 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.